Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 1, 2009, Pages 49-55

  Nagilla, R ^a,b   Deshmukh, D D ^a,b   Copedge, K J ^c   Miller, S ^c   Martin, B ^c   Bell, E C ^d   Duran, S H ^e   Ravis, W R ^b  

^a GLAXOSMITHKLINE   (United States)

^b AUBURN UNIVERSITY   (United States)

^c TUSKEGEE UNIVERSITY   (United States)

^d TEXAS SOUTHERN UNIVERSITY   (United States)

^e AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; ENANTIOMER; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEREOSPECIFICITY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GOATS; HALF-LIFE; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; KETOROLAC; MALE; METABOLIC CLEARANCE RATE; RANDOM ALLOCATION; STEREOISOMERISM;

CAPRA HIRCUS;

EID: 58449132084     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00999.x     Document Type: Article

References (24)

1. Anderson, K., Hunt, E. Davis, B.J. (1991) The influence of anti-inflammatory therapy on bacterial clearance following intramammary Escherichia coli challenge in goats. Veterinary Research Communications, 15, 147 161.
2. Dalvi, R.R., Nunn, V.A. Juskevich, J. (1987) Hepatic cytochrome P-450 dependent drug metabolizing activity in rats, rabbits and several food-producing species. Journal of Veterinary Pharmacology and Therapeutics, 10, 164 168.
3. Gibson, G.G. Skett, P. (1986) Pathways to drug metabolism. In Introduction to Drug Metabolism, pp. 1 37. Chapman & Hall, New York, NY.
4. Guzman, A., Yuste, F., Toscano, R.A., Young, J.M. Van Horn, A.R. (1986) Absolute configuration of (-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1- carboxylic acid, the active enantiomer of ketorolac. Journal of Medicinal Chemistry, 29, 589 591.
5. Hamunen, K., Maunuksela, E.-L., Sarvela, J., Bullingham, R.E.S. Olkkola, K.T. (1999) Stereoselective pharmacokinetics of ketorolac in children, adolescents and adults. Acta Anaesthesiologica Scandinavica, 43, 1041 1046.
6. Hayball, P.J.H. (1996) Chirality and nonsteroidal anti-inflammatory drugs. Drugs, 52, 47 58.
7. Hayball, P.J., Wrobel, J., Tramblyn, J.G. Nation, R.L. (1994) The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate. British Journal of Clinical Pharmacology, 37, 75 78.
8. Hutt, A.J. Tan, S.C. (1996) Drug chirality and significance. Drugs, 52, 1 12.
9. Jamali, F. (1988) Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drug. European Journal of Drug Metabolism and Pharmacokinetics, 13, 1 9.
10. Jamali, F., Lovlin, R., Corrigan, B.W., Davies, N.M. Aberg, G. (1999) Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat. Chirality, 11, 201 205.
11. Kauffman, R.E., Leih-Lai, M.W., Uy, H.G. Aravind, M.K. (1999) Enantiomer selective pharmacokinetics and metabolism of ketorolac in children. Clinical Pharmacology and Therapeutics, 65, 382 388.
12. Moses, V.S. Bertone, A.L. (2002) Nonsteroidal anti-inflammatory drugs. The Veterinary Clinics of North America. Equine Practice, 18, 21 37.
13. Mroszczak, E., Lee, W.F., Combs, D., Sarnquist, F.H., Huang, B.L., Wu, A-T., Tokes, L.G., Maddox, M.L. Cho, D.K. (1987) Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans. Drug Metabolism and Disposition, 15, 618 626.
14. Mroszczak, E.J., Jung, D., Yee, J., Bynum, L., Sevelius, H. Massey, I. (1990) Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular and oral administration in humans and animals. Pharmacotherapy, 10 (6 Pt 2 33S 39S.
15. Mroszczak, E., Combs, D., Chaplin, M., Tsina, I., Tarnowski, T., Rocha, C., Tam, Y., Boyd, A., Young, J. Depass, L. (1996) Chiral kinetics and dynamics of ketorolac. Journal of Clinical Pharmacology, 36, 521 539.
16. Nagilla, R., Deshmukh, D.D., Duran, S.H. Ravis, W.R. (2007) Stereospecific pharmacokinetics of ketorolac tromethamine in calves following single intravenous and oral doses. Journal of Veterinary Pharmacology and Therapeutics, 30, 437 442.
17. Pasloske, K., Renaud, R., Burger, J. Conlon, P. (1999) Pharmacokinetics of ketorolac after intravenous and oral single administration in dogs. Journal of Veterinary Pharmacology and Therapeutics, 22, 314 319.
18. Resman-Targoff, B.H. (1990) Ketorolac: a parenteral nonsteroidal anti-inflammatory drug. Drug Intelligence & Clinical Pharmacy, 24, 1098 1104.
19. Rooks, W.H., Tomolonis, A.J. II, Maloney, P.J., Wallach, M.B. Schuler, M.E. (1982) The analgesic and anti-inflammatory profile of (+)-5-benzoyl-1,2- dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619). Agents and Actions, 12, 684 690.
20. Santos, Y., Ballesteros, C., Ros, J.M., Lazaro, R., Rodriguez, C. Encinas, T. (2001) Chiral pharmacokinetics of ketorolac in sheep after intravenous and intramuscular administration of the racemate. Journal of Veterinary Pharmacology and Therapeutics, 24, 443 446.
21. Shargel, L. Yu, A. (1999) Pharmacokinetics of oral absorption. In Applied Biopharmaceutics and Pharmacokinetics, 4th edn, pp. 223 245. McGraw-Hill, New York.
22. Short, C.R., Flory, W., Hsieh, L.C., Aranas, T., Ou, S.P. Weissinger, L. (1988) Comparison of hepatic drug metabolizing capacity in several agricultural species. Comparative Biochemistry and Physiology, 91C, 419 424.
23. Smith, M.A. Sherman, D.M. (1994) Goat Medicine, pp. 465 494. Lea & Febiger, Baltimore.
24. Zornoza, T., Cano-Cebria'n, M.J., Hipo'lito, L., Granero, L. Polache, A. (2006) Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats. Biopharmaceutics and Drug Disposition, 27, 305 311.